Skip to main content

Autoimmune & autoinflammatory

Vogt-Koyanagi-Harada

Vogt-Koyanagi-Harada disease is an autoimmune attack on melanocytes - blurring both eyes with fluid under the retina, alongside headache, hearing symptoms, and later skin and hair whitening.

Key points

The essentials at a glance.

What to look out for, which tests matter, who treats it, and what usually happens next.

  • Acute phase: bilateral blurred vision from serous retinal detachments, often preceded by headache, neck stiffness and ear ringing

  • Attacks melanin-containing tissue: the uvea, inner ear, meninges, skin and hair

  • Late signs if undertreated: patches of vitiligo, whitened eyelashes (poliosis), and the orange-red sunset glow fundus

  • More common in darker-pigmented populations, typically ages 20-50

  • Early high-dose steroids with a slow taper, plus early steroid-sparing immunosuppression, protect vision and prevent recurrence

Understanding it

About Vogt-Koyanagi-Harada.

VKH announces itself in stages: a flu-like prelude with headache, scalp tenderness and tinnitus as the immune system inflames melanocyte-rich meninges and inner ear, then within days both eyes blur as inflammation floods fluid beneath the retinas - the bilateral serous detachments that OCT scanning displays exquisitely. Untreated or undertreated, inflammation smoulders into the chronic phase, depigmenting the fundus to a sunset glow, whitening lashes and skin, and generating the cataract, glaucoma and scarring that destroy sight.

The treatment lesson from two decades of studies is front-loaded aggression: high-dose corticosteroids the moment infection and mimics are excluded, tapered over months not weeks, with early addition of steroid-sparing agents in disease that recurs as steroids withdraw. Managed this way, most patients keep good vision; managed timidly, VKH becomes a lifelong relapsing uveitis - so care belongs with a uveitis specialist from the first week. In many parts of the UK, a routine NHS referral to the relevant specialist clinic currently means waiting many months - sometimes more than a year for the rarest conditions - whereas an initial appointment with a private consultant is typically available within around two weeks, with investigations arranged soon after.

Frequently asked

Common questions about Vogt-Koyanagi-Harada.

Quick, plain-English answers to what people ask us most.

  • What is Vogt-Koyanagi-Harada disease?

    It is a rare autoimmune condition in which the immune system attacks pigmented cells (melanocytes) throughout the body, causing inflammation of the eyes (uveitis) along with skin, hair, and, sometimes, inner ear and nervous system involvement.

  • What causes Vogt-Koyanagi-Harada disease?

    It's an autoimmune condition in which the immune system mistakenly targets melanocyte-containing tissues, though the exact trigger for this abnormal immune response isn't fully understood.

  • What are the symptoms of Vogt-Koyanagi-Harada disease?

    Symptoms often start with flu-like illness and headache, followed by eye symptoms (blurred vision, eye pain, light sensitivity), and later, skin changes including patches of light skin or hair, and sometimes hearing changes.

  • Is Vogt-Koyanagi-Harada disease dangerous?

    Yes, without prompt treatment, the eye inflammation can lead to significant vision loss, so this is treated as a serious condition needing urgent specialist assessment and sustained treatment.

  • Can Vogt-Koyanagi-Harada disease be treated?

    Yes, high-dose corticosteroids, often followed by other immune-modulating medications, are effective at controlling the inflammation and preserving vision, particularly when started early.

  • How is Vogt-Koyanagi-Harada disease treated?

    Treatment typically starts with high-dose oral or intravenous corticosteroids, often continued for a prolonged period with a gradual taper, sometimes alongside other immunosuppressive medication to allow steroid doses to be reduced.

  • How long does treatment for Vogt-Koyanagi-Harada disease last?

    Treatment often continues for many months to over a year, given the tendency for inflammation to recur if steroids are reduced too quickly, with close monitoring by an ophthalmologist throughout.

  • Vogt-Koyanagi-Harada disease vs sympathetic ophthalmia - what's the difference?

    Both cause a similar pattern of autoimmune eye inflammation, but sympathetic ophthalmia occurs specifically after eye injury or surgery to one eye, causing inflammation in both eyes, while Vogt-Koyanagi-Harada disease occurs without such a preceding eye injury.

  • When should I see a specialist, and how quickly can I be seen privately?

    See an ophthalmologist urgently for symptoms of eye inflammation with vision changes. NHS urgent ophthalmology assessment aims for rapid review; private ophthalmologists can often see you within about one to two weeks for non-urgent follow-up.